https://www.selleckchem.com/pr....oducts/halofuginone.
25, 95% CI, 1.36-3.71, P = 0.002; A vs. G adjusted OR = 1.44, 95% CI, 1.15-1.80, P = 0.001, respectively). Haplotype analysis showed that rs884309G- rs1464938A haplotype was associated with an increased risk of TCC (OR = 1.61, 95% CI, 1.23-2.11, P = 0.001). Functional analysis showed that the rs1464938 AG/AA genotypes exhibited higher levels of FGF12 mRNA in TCC tissues and the rs1464938 A allele enhanced FGF12 promoter activity (P less then 0.05). These findings suggest that the rs1464938 A allele at the 3q28 locus contribute to t
Like
Comment
Share
